D. Haraf

1.1k citations

34 papers · 878 indexed · h-index 13

Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies 15
Oncology top 10%
- Lung Cancer Research Studies 7
- Cancer Treatment and Pharmacology 5
- Cancer Diagnosis and Treatment 5
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 7
Surgery top 10%
- Head and Neck Surgical Oncology 4
Oral Surgery top 10%
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 3

Co-authors: Everett E. Vokes Ralph R. Weichselbaum Rosemarie Mick W. R. Panje P C Hoffman Ann M. Mauer Gregory A. Masters Harvey M. Golomb
Cited by: Otorhinolaryngology Oncology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology (15 papers)Lung Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
Partner nations: United States France

In The Last Decade

D. Haraf

33 papers receiving 856 citations

Peers

Countries citing papers authored by D. Haraf

Since Specialization

Citations

This map shows the geographic impact of D. Haraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Haraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Haraf more than expected).

Fields of papers citing papers by D. Haraf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Haraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Haraf. The network helps show where D. Haraf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Haraf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Haraf Line = papers co-authored together D. Haraf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer Lung Cancer ·Dean A. Shumway,Kimberly S. Corbin,Ravi Salgia,P C Hoffman,Victoria Villaflor,Vaibhavi Pathade,D. Haraf,N. L. ALLAN,高柳広,Philip P. Connell,Mark K. Ferguson,Joseph K. Salama	2011	16
2	A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer (HNC) Journal of Clinical Oncology ·Everett E. Vokes,Tanguy Y. Seiwert,健一袴田,Ezra E.W. Cohen,Joseph K. Salama,Victoria Villaflor,Claudia M. Witt,Milica Kovačević Filipović,Kerstin Stenson,D. Haraf	2008	4
3	A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer Journal of Clinical Oncology ·Tanguy Y. Seiwert,W.A. Duggins,Ann M. Mauer,P. C. Hoffman,Christopher George,Livia L. Szeto,Coleman K. Obasaju,D. Haraf,Ravi Salgia,Everett E. Vokes	2005	11
4	Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer: Toxicity and outcome results Journal of Clinical Oncology ·Joseph K. Salama,D. Haraf,Taesup Kim,Everett E. Vokes	2004	1
5	A phase I study of cisplatin, tirapazamine and accelerated re-irradiation in unresectable recurrent head and neck cancer Journal of Clinical Oncology ·Ezra E.W. Cohen,Dominique Rosine,Elwyn Loh,D. Haraf,Everett E. Vokes,韮澤融司	2004	1
6	O-308 A phase I trial of pemetrexed + chest radiotherapy in patients with advanced or metastatic non-small-cell lung cancer or esophageal cancer Lung Cancer ·Everett E. Vokes,Livia L. Szeto,Ann M. Mauer,S Krauß,Charles M. Rudin,L. Kayitalire,P C Hoffman,D. Haraf	2003	10
7	Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. PubMed ·Editorial – Chamada para Publicação,Everett E. Vokes,Yosef Lopez,M.E. Witt,Ralph R. Weichselbaum,D. Haraf	1999	46
8	Phase I study of docetaxel with concomitant thoracic radiation therapy. Journal of Clinical Oncology ·Ann M. Mauer,Gregory A. Masters,D. Haraf,P C Hoffman,Marina Pedrol-Aguilà,Harvey M. Golomb,Everett E. Vokes	1998	129
9	Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. Journal of Clinical Oncology ·Bruce Brockstein,D. Haraf,Taesup Kim,Adedigbo A. Fasanmade,Roger Stupp,Bonnie S. Glisson,Scott M. Lippman,Mark J. Ratain,杨旭,Erin Thompson,R.R. Weichselbaum,Everett E. Vokes	1998	62
10	Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysis Annals of Oncology ·P C Hoffman,D. Haraf,Mark K. Ferguson,Viive Kõvask,Everett E. Vokes	1998	11
11	Quality of life (QL) and performance outcome in survivors of concomitant chemoradiotherapy protocols for head and neck cancer (HNC) (Meeting abstract). Rehabilitation Oncology ·Lina Ximena García Fajardo,Patricia Mumby,D. Haraf,Liu Xuequan,Artur Mędlara,Rosemarie Mick,Ersagun TÜRKDOĞRU,Everett E. Vokes	1997	2
12	Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. Journal of Clinical Oncology ·Everett E. Vokes,Rosemarie Mick,M.S. Kies,M. Eileen Dolan,Artur Mędlara,Ilias Athanasiadis,D. Haraf,Mark Kozloff,Ralph R. Weichselbaum,Mark J. Ratain	1996	48
13	Treatment of prostate cancer using external beam radiotherapy after laparoscopic pelvic lymph node dissection British Journal of Urology ·Glenn S. Gerber,Gregory T. Bales,Heather L. Gornik,D. Haraf,Gerald W. Chodak,Daniel B. Rukstalis	1996	5
14	Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. PubMed ·D. Haraf,Edwardine Nodzenski,David Brachman,Rosemarie Mick,Mehrdad Nabahat,N. S. Pis’mennaya,Everett E. Vokes,Ralph R. Weichselbaum	1996	141
15	Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. Journal of Clinical Oncology ·Everett E. Vokes,M.S. Kies,D. Haraf,Rosemarie Mick,W J Moran,Mark Kozloff,Bharat B. Mittal,Harold J. Pelzer,Barry L. Wenig,W. R. Panje	1995	88
16	Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. Journal of Clinical Oncology ·Everett E. Vokes,D. Haraf,Rosemarie Mick,三河洋平,Ralph R. Weichselbaum	1994	54
17	SWALLOWING FUNCTION FOLLOWING MULTISPECIALTY ORGAN PRESERVATION TREATMENT OF ADVANCED HEAD AND NECK-CANCER Oncology Reports ·UmaruH Pindiga,Ellen MacCracken,W J Moran,Everett E. Vokes,D. Haraf,Jiya Lian	1994	9
18	Locoregionally Advanced Paranasal Sinus Carcinoma: Favorable Survival With Multimodality Therapy Archives of Otolaryngology - Head and Neck Surgery ·A. Rosen,Everett E. Vokes,M MOSHKANIFARAHANI,D. Haraf,Ralph R. Weichselbaum,W. R. Panje	1993	50
19	Favorable Long-Term Survival Following Induction Chemotherapy With Cisplatin, Fluorouracil, and Leucovorin and Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Cancer JNCI Journal of the National Cancer Institute ·Everett E. Vokes,C Borghi,Rosemarie Mick,三河洋平,D. Haraf,W. R. Panje	1992	82
20	Temporal bone chemodectomas--comparing surgery and radiation therapy. PubMed ·Yuko Tokoro,D. Haraf,Ralph R. Weichselbaum	1991	31

About D. Haraf

D. Haraf is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Radiation and Surgery, having authored 34 papers that have together received 878 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (15 papers), Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Diagnosis and Treatment (5 papers), Head and Neck Surgical Oncology (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Otorhinolaryngology (478 citations), Oncology (431 citations), Pulmonary and Respiratory Medicine (325 citations), Surgery (418 citations) and Oral Surgery (38 citations). D. Haraf has collaborated with scholars based in United States and France. Frequent co-authors include Everett E. Vokes, Ralph R. Weichselbaum, Rosemarie Mick, W. R. Panje, P C Hoffman, Ann M. Mauer, Gregory A. Masters, Harvey M. Golomb, David Brachman and Edwardine Nodzenski. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, JNCI Journal of the National Cancer Institute and Oncology Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact